RNRMarketResearch.com

+8% CAGR Growth to Be achieved By Vaccines Market Reaching $48.03 Billion by 2021

Press Release   •   Feb 10, 2017 06:02 EST

The report "Vaccines Market by Technology (Live Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant), Disease Indication (Pneumococcal, Influenza, HPV, Hepatitis, Rotavirus, DTP, Polio, MMR), End User (Pediatrics, Adults) & Type - Forecasts to 2021" Projects the market to Surge at a CAGR of 8+% and hit $ 48.03 Billion by 2021

Based on end-users, the vaccines market is segmented into paediatrics and adults. The pediatrics segment is expected to account for the largest share of the market in 2016. Increasing prevalence of diseases in children and the rising number of awareness programs to promote vaccination will drive the growth of this market.

Browse 89 market data Tables and 55 Figures spread through 158 Pages and in-depth TOC on "Vaccines Market by Technology (Live Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant), Disease Indication (Pneumococcal, Influenza, HPV, Hepatitis, Rotavirus, DTP, Polio, MMR), End User (Pediatrics, Adults) & Type - Forecasts to 2021" http://www.rnrmarketresearch.com/vaccine-market-by-technology-types-trend-analysis-by-various-classes-live-attenuated-subunit-toxoid-conjugate-dna-recombinant-vector-synthetic-dentritic-vaccines-and-by-indications-i-market-report.html

Geographically, the vaccines market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rising government funding for vaccine research in the North American countries.

On the basis of disease indication, the vaccines market is segmented into pneumococcal disease, influenza, diphtheria, tetanus, and pertussis (DTP), hepatitis, rotavirus, varicella, meningococcal disease, polio, measles, mumps, and rubella (MMR), human papilloma virus (HPV) infection, and others. Pneumococcal disease segment is expected to account for largest share in 2016. This is attributed to the high incidence of pneumococcal infections and increasing initiatives by government organization for immunizations.

The major factors contributing to the growth of the vaccines market include high prevalence of diseases, rising government and nongovernment funding for vaccine development, and increasing focus on immunization programs. Furthermore, increasing R&D spending and new vaccine development activities by companies is another major factor driving the growth of this market.

The Companies profiled in this report are

Pfizer, Inc.
Glaxosmithkline, PLC.
Merck & Co., Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions, Inc.
Johnson & Johnson
Medimmune, LLC. (A Subsidiary of Astrazeneca)
Astellas Pharma Inc.
Serum Institute of India

Now avail Discount on this Report at : http://www.rnrmarketresearch.com/contacts/discount?rname=110437

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the vaccines market. The report analyses the vaccines market by technology, type, disease indication, end-users, and regions

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the vaccines market

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the vaccines market

Market Development: Comprehensive information about emerging markets. This report analyses the market for various vaccines across geographies

Market Diversification: Exhaustive information about new vaccines, untapped geographies, recent developments, and investments in the vaccines market

Request a Sample Copy of This Report Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=110437

The Report Provides Insights and Data on

Nih Funding for Vaccine Research, 2012-2016 (USD Million)

Market Size, By Technology, 2014–2021 (USD Million)

Conjugate Vaccines Market Size, By Region, 2014–2021 (USD Million)

Examples of Inactivated and Subunit VaccinesInactivated and Subunit Vaccines Market Size, By Region, 2014–2021 (USD Million)

Live Attenuated Vaccines Market Size, By Region, 2014–2021 (USD Million)

Toxoid Vaccines Market Size, By Region, 2014–2021 (USD Million)

Recombinant Vaccines Market Size, By Region, 2014–2021 (USD Million)

Vaccines Market Size, By Type, 2014–2021 (USD Million)

Monovalent Vaccines Market Size, By Region, 2014–2021 (USD Million)

Multivalent Vaccines Market Size, By Region, 2014–2021 (USD Million)

Market Size for Pneumococcal Disease, By Region, 2014–2021 (USD Million)

Market Size for DTP, By Region, 2014–2021 (USD Million)

Market Size for Influenza, By Region, 2014–2021 (USD Million)

Market for Hpv, By Region, 2014–2021 (USD Million)

Market Size for Meningococcal Disease, By Region, 2014–2021 (USD Million)

Polio Market Size, By Region, 2014–2021 (USD Million)

Market Size for Rotavirus, By Region, 2014–2021 (USD Million)

Market Size for Hepatitis, By Region, 2014–2021 (USD Million)

Market Size for MMR, By Region, 2014–2021 (USD Million)

Market Size for Varicella, By Region, 2014–2021 (USD Million)

Market Size for Other Diseases, By Region, 2014–2021 (USD Million)

Market Size for Pediatrics, By Region, 2014–2021 (USD Million)